Europe In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

List of Tables

The Europe in-vitro diagnostics market is expected to grow from US$ 22,616.55 million in 2022 to US$ 34,247.12 million by 2030. It is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic Fuels Europe In-Vitro Diagnostics Market

IVDs that are used in the diagnosis of infectious diseases include immunoassays, and molecular assays. Diagnostics companies also focus on making rapid advancements in their offerings to manage COVID-19. Further, regulatory authorities introduced temporary amendments or modifications to their standards, which favored the launches of new IVDs during the pandemic. The demand for molecular diagnostics and immunoassays surged due to these government initiatives. Moreover, many companies expanded their product lines for IVD manufacturing.

In June 2021, the British In Vitro Diagnostics Association (BIVDA) launched "The Digital Revolution" strategy to encourage breakthroughs in in-vitro diagnostics during the COVID-19 pandemic. In July 2022, BioGX announced the launch of a CE-marked, three-gene point-of-care (POC) multiplex COVID-19 test on its Pixel platform. Thus, the COVID-19 pandemic has benefitted the in-vitro diagnostics market due to the rising demand for point-of-care (POC) diagnostics and laboratory testing procedures.

Europe In-Vitro Diagnostics Market Overview

The Europe in-vitro diagnostics market has been segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. The market growth in this region is attributed to the rising awareness of the disease diagnosis, increasing ageing population, and technological advancements in in-vitro diagnostics thereby dominating the overall market growth. Germany accounts for the largest share of the in-vitro diagnostic (IVD) market in Europe. The German IVD industry is known for its innovation capabilities. Its IVD industry benefits from developments in molecular biology, miniaturization, and automation. The German "Industrie 4.0" project is undergoing digitalization, particularly in ICD, with "Lab 4.0" developed for data handling, cloud-based IT solutions, lab and production automation processes, and digital networking.

The IVD market in Germany experienced an enormous rise in demand amid the COVID-19 pandemic. Comprehensive testing was a central component of the German government's health policy strategy to combat the pandemic and protect the population from infection. Companies based in Germany are proven innovators in developing molecular tests as well as high-tech instruments and consumables that are used in the bioanalysis of molecular information. Developments of in-vitro diagnostics through innovative product launches by companies with automation systems in labs boost the in-vitro diagnostics market in Germany.

Europe In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe In-Vitro Diagnostics Market Segmentation

The Europe in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on end user, the Europe in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on country, the Europe in-vitro diagnostics market is segmented int o Germany, France, UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe in-vitro diagnostics market.

Product Code: TIPRE00022122

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe In-Vitro Diagnostics Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
- 4.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
4.2 Market Restraint
- 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
- 4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
- 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. In-Vitro Diagnostics Market - Europe Market Analysis

5.1 Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

6.1 Overview
6.2 Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
- 6.3.1 Overview
- 6.3.2 Reagents and Kits: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
- 6.4.1 Overview
- 6.4.2 Software and Services: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
- 6.5.1 Overview
- 6.5.2 Instruments: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview
7.2 Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
- 7.3.1 Overview
- 7.3.2 Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
- 7.4.1 Overview
- 7.4.2 Clinical Chemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
- 7.5.1 Overview
- 7.5.2 Molecular Diagnostics: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
- 7.6.1 Overview
- 7.6.2 Microbiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
- 7.7.1 Overview
- 7.7.2 Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
- 7.8.1 Overview
- 7.8.2 Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
- 7.9.1 Overview
- 7.9.2 Hematology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
- 7.10.1 Overview
- 7.10.2 Urinalysis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
- 8.5.1 Overview
- 8.5.2 Oncology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
- 8.6.1 Overview
- 8.6.2 Cardiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
- 8.7.1 Overview
- 8.7.2 Autoimmune Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
- 8.8.1 Overview
- 8.8.2 Nephrology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
- 9.4.1 Overview
- 9.4.2 Laboratories: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe In-Vitro Diagnostics Market
- 10.1.1 Overview
- 10.1.2 Europe In-Vitro Diagnostics Market, by Country
  - 10.1.2.1 Germany: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 Germany: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.1.4 Germany: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.1.5 Germany: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.6 Germany: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.2 France: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 France: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 France: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.2.4 France: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.2.5 France: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.6 France: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.3 UK: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 UK: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 UK: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.3.4 UK: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.3.5 UK: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.6 UK: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.4 Italy: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Italy: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Italy: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Italy: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.6 Italy: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.5 Spain: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 Spain: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.5.4 Spain: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.5.5 Spain: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.6 Spain: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Europe: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.6 Rest of Europe: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

11.1 Organic Developments
- 11.1.1 Overview
11.2 Inorganic Developments
- 11.2.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Siemens AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sysmex Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Becton Dickinson and Co
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Qiagen NV
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms